Clinical Trial Update: Divided or Single Exposure (DOSE) Study [Phase 2, Phase 3]

View source ↗

Summary

This ClinicalTrials.gov entry notes that the DOSE study, a Phase 2/Phase 3 trial sponsored by the University of Maryland, Baltimore, is currently recruiting to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Pain

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Opioid Use Disorder, Chronic Pain | Phase 2, Phase 3 | Status: RECRUITING